Zurich Cantonal Bank’s BioLife Solutions BLFS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$482K Buy
17,054
+3,942
+30% +$92.1K ﹤0.01% 1964
2026
Q1
$250K Buy
13,112
+5,422
+71% +$120K ﹤0.01% 2168
2025
Q4
$186K Hold
7,690
– – ﹤0.01% 2247
2025
Q3
$196K Hold
7,690
– – ﹤0.01% 2204
2025
Q2
$166K Hold
7,690
– – ﹤0.01% 2215
2025
Q1
$176K Hold
7,690
– – ﹤0.01% 2167
2024
Q4
$200K Hold
7,690
– – ﹤0.01% 2153
2024
Q3
$193K Hold
7,690
– – ﹤0.01% 2125
2024
Q2
$165K Hold
7,690
– – ﹤0.01% 2134
2024
Q1
$143K Hold
7,690
– – ﹤0.01% 2228
2023
Q4
$125K Hold
7,690
– – ﹤0.01% 2342
2023
Q3
$106K Hold
7,690
– – ﹤0.01% 2328
2023
Q2
$170K Buy
7,690
+3,823
+99% +$80.5K ﹤0.01% 2033
2023
Q1
$84.1K Hold
3,867
– – ﹤0.01% 2380
2022
Q4
$70.4K Hold
3,867
– – ﹤0.01% 2478
2022
Q3
$88K Hold
3,867
– – ﹤0.01% 2320
2022
Q2
$53K Hold
3,867
– – ﹤0.01% 2562
2022
Q1
$88K Hold
3,867
– – ﹤0.01% 2337
2021
Q4
$144K Hold
3,867
– – ﹤0.01% 2294
2021
Q3
$164K Hold
3,867
– – ﹤0.01% 2041
2021
Q2
$172K Hold
3,867
– – ﹤0.01% 1904
2021
Q1
$139K Sell
3,867
-992
-20% -$39.2K ﹤0.01% 1992
2020
Q4
$194K Buy
+4,859
New +$166K ﹤0.01% 1862

Other funds holding BLFS

Zurich Cantonal Bank's BLFS Position: Q2 2026 in Review

Zurich Cantonal Bank increased its BioLife Solutions (BLFS) stake by 30% in Q2 2026, buying an estimated $92.1K and bringing the position to 17,054 shares worth $482K. The position accounts for ﹤0.01% of the portfolio, ranked #1964.

Zurich Cantonal Bank first reported a position in BLFS in Q4 2020 and has held it in 23 quarters since. 216 funds tracked by Wall St. Rank hold BLFS as of Q2 2026.

  • Zurich Cantonal Bank held 17,054 shares of BioLife Solutions worth $482K as of Q2 2026.
  • Zurich Cantonal Bank bought 3,942 BioLife Solutions shares in Q2 2026, an estimated $92.1K.
  • BioLife Solutions made up ﹤0.01% of Zurich Cantonal Bank's portfolio in Q2 2026, its #1964 holding.
  • Zurich Cantonal Bank first reported a position in BioLife Solutions in Q4 2020 and has held it in 23 quarters since.
  • 216 funds tracked by Wall St. Rank held BioLife Solutions as of Q2 2026.

Based on Zurich Cantonal Bank's 13F filing for Q2 2026, filed 12 Aug 2026.